We also found that there is a CSF3R-AS/CSF3R/JAK2/STAT3 positive feedback loop in HCC, which plays important roles in promoting HCC progression and sorafenib resistance, and the blockade of this loop is expected to provide a novel therapeutic target for HCC. The gene discussed is JAK2; the disease is hepatocellular carcinoma.